All News about Takeda Pharmaceutical Ltd ADR![]() ![]() ![]() ![]() ![]()
HUTCHMED Out Licenses Fruquintinib To Takeda Outside China
January 23, 2023
Via Benzinga
![]()
A Bullish Sign Appears On Takeda Pharmaceutical's Chart
December 28, 2022
Via Benzinga
![]()
Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B
December 13, 2022
Via Benzinga
![]() ![]()
Takeda Named Global Top Employer for Sixth Consecutive Year
January 16, 2023
Via Business Wire
![]() Via Talk Markets
![]() ![]()
Takeda's Dengue Vaccine Candidate Under FDA Priority Review
November 23, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|